多种IL-17家族细胞因子通过IL-17受体A驱动银屑病相关炎症通路
本研究探讨了IL-17家族细胞因子在银屑病中的贡献。通过分析银屑病患者皮损与非皮损皮肤,发现IL-17A、IL-17F、IL-17A/F和IL-17C在皮损中表达升高,并在体外培养的人皮肤中诱导与银屑病转录组特征相关的重叠基因表达反应。Brodalumab(而非ixekizumab)能正常化这些细胞因子组合诱导的基因表达反应。
要点
- IL-17A、IL-17F、IL-17A/F和IL-17C在银屑病皮损中表达升高。
- 这些细胞因子通过IL-17RA信号传导,诱导重叠的银屑病相关炎症基因表达。
- Brodalumab可正常化IL-17家族细胞因子组合诱导的基因表达反应。
核心结论
- 多种通过IL-17RA信号传导的IL-17配体在银屑病皮肤中过表达,并诱导相似的银屑病相关炎症通路。
研究设计与样本
- 分析银屑病患者皮损和非皮损皮肤样本,采用定量聚合酶链反应、免疫分析、原位杂交和免疫组化。
- 使用体外培养的人皮肤活检组织和原代人角质形成细胞进行功能活性机制研究。
主要发现
- IL-17A、IL-17F、IL-17A/F和IL-17C在银屑病皮损中表达水平升高。
- 这些细胞因子在体外培养的人皮肤中诱导重叠的基因表达反应,与银屑病皮肤转录组特征相关。
- Brodalumab与ixekizumab不同,能正常化IL-17A、IL-17F、IL-17A/F和IL-17C组合在人角质形成细胞中诱导的基因表达反应。
临床怎么用
- 靶向IL-17RA可能比仅靶向IL-17A更广泛地阻断银屑病相关炎症通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The interleukin (IL)-23/IL-17 immune axis is of central importance in psoriasis. However, the impact of IL-17 family cytokines other than IL-17A in psoriasis has not been fully established. OBJECTIVES: To elucidate the contribution of IL-17 family cytokines in psoriasis. METHODS: To address the expression and localization of IL-17 family cytokines, lesional and nonlesional skin samples from patients with psoriasis were analysed by several complementary methods, including quantitative polymerase chain reaction, immunoassays, in situ hybridization and immunohistochemistry. Mechanistic studies assessing the functional activity of IL-17 family cytokines were performed using ex vivo cultured human skin biopsies and primary human keratinocytes. RESULTS: We demonstrated that IL-17A, IL-17F, IL-17A/F and IL-17C are expressed at increased levels in psoriasis lesional skin and induce overlapping gene expression responses in ex vivo cultured human skin that correlate with the transcriptomic signature of psoriasis skin. Furthermore, we showed that brodalumab, in contrast to ixekizumab, normalizes gene expression responses induced by the combination of IL-17A, IL-17F, IL-17A/F and IL-17C in human keratinocytes. CONCLUSIONS: Several IL-17 ligands signalling through IL-17RA are overexpressed in psoriasis skin and induce similar psoriasis-related inflammatory pathways demonstrating their relevance in relation to therapeutic intervention in psoriasis.
引用
- Tollenaere MAX, Hebsgaard J, Ewald DA, et al. Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways. Br J Dermatol. 2021. PMID: 33792895. doi:10.1111/bjd.20090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。